First-in-Human Trial Shows PEGylated Uricase HZBio1 Is Well Tolerated and Slashes Uric Acid
A first-in-human phase 1a trial in China found that single intramuscular doses of the PEGylated recombinant uricase HZBio1 were well ...
A first-in-human phase 1a trial in China found that single intramuscular doses of the PEGylated recombinant uricase HZBio1 were well ...
A rat study found that the anticancer drug anlotinib substantially increases blood levels of the antihypertensive amlodipine, raising safety concerns ...
A phase 2 dose-finding trial found that a single oral dose of the netupitant-palonosetron combination NEPA effectively prevented chemotherapy-induced nausea ...
A clinical trial finds that the traditional Korean formulations Bojungikgitang and Cheongsanggyeontongtang substantially raise or lower edoxaban exposure in healthy ...
A randomized crossover trial in 52 healthy Chinese adults found that a generic teneligliptin hydrobromide tablet met all regulatory bioequivalence ...
A new review argues that melatonin's non-sleep therapeutic claims must be re-evaluated through measured drug exposure, since oral bioavailability is ...
A comprehensive review maps how food, acid-reducing drugs and liver enzymes alter the exposure of thirty lung cancer targeted therapies, ...
A phase 1b study presented at the IASLC 2026 World Conference on Lung Cancer found that subcutaneous tarlatamab was well ...
A 2026 Journal of Perinatology study examines how bilirubin production, distribution, and clearance differ in preterm infants, informing safer jaundice ...
A new computational study shows that piperine, the pungent alkaloid of black pepper, binds the Parkinson's-related MAO-B enzyme more strongly ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine